Published June 25, 2018 | Version v1
Journal article Open

Effect of Camel Milk on Lipid Metabolism in Type 1 Diabetic Patients

Authors/Creators

  • 1. Department of Biochemistry, Faculty of Medicine and Health Sciences, University of Gadarif, Sudan
  • 2. Department of Pediatrics, Faculty of Medicine & Health Sciences, University of Gadarif, Sudan

Description

Abstract

Treatment of lipid abnormalities and hypercholesterolemia associated with diabetes and non-diabetes is a medical dilemma as current lipid-lowering drugs cause serious and sometimes fatal side effects. There have been a few attempts to explore natural medicines to unravel this dilemma. This study has investigated the efficacy of Sudanese Camelus dromedary’s raw milk on lipid metabolism in 30 type 1 diabetic patients for 12 month. The patients were randomly divided into two groups. Control group (N=15 patients), received usual medical care and study group (N=15 patients), received the same medical care as for group 1, in addition to 0.5 L/day of raw dromedary’s camel milk that was consumed by 250 ml twice/day in the morning and evening. Camel milk has proven very effective in improving lipid metabolism in the subjects who received it. It significantly reduced the bad lipids i.e. total cholesterol by 35% (from 138 ± 52 mg/dl to 89.5 ± 29.5 mg/dl; P < 0.0001), low density lipoprotein by 78% (from 121.5 ± 56.5 mg/dl to 27 ± 16 mg/dl; P < 0.0001), very low density lipoprotein by 33% (from 20.97 ± 10.05 mg/dl to 13.5 ± 5.5 mg/dl; P = 0.0121) and triglycerides by 33% (from 100 ± 51 mg/dl to 67.5 ± 27.5 mg/dl; P = 0.0121). At the meantime camel milk significantly raised the “good cholesterol” the HDL by 236.5% (from 63 ± 37 mg/dl to 212 ± 72 mg/dl; P < 0.0001). This was in contrast to the lipid parameters of the subjects who did not received camel milk as their lipid parameters did not improve. It seems that dromedary’s camel milk works well with the body’s own restorative and regenerative mechanisms to overcome any metabolic aberrations in lipid metabolism that might resulted from diabetes mellitus and from other factors. Camel milk is very well tolerated and it is absolutely safe for human uses. Thus, dromedary’s camel milk can safely be used as an alternative medicine to treat lipid abnormalities and hypercholesterolemia associated with diabetes or that resulted from other factors. The mechanism by which dromedary’s camel milk effectively improves lipid metabolism in type 1 diabetic patients needs further studies.

Notes

Biomedical Research and Reviews (ISSN:2631-3944)

Files

acs-1-102.pdf

Files (2.3 MB)

Name Size
md5:eb2c960b09df214a5eba1e3008b5493d
2.3 MB Preview Download

Additional details

Related works

Is published in
Journal article: https://www.boffinaccess.com/biomedical-research-reviews/effect-of-camel-1-102 (URL)
Journal article: https://www.boffinaccess.com/biomedical-research-reviews/effect-of-camel-1-102/brr-1-102.pdf (URL)

References

  • Abdalla KO, Fadlalla AA. Effects of Sudanese Dromedary's CamelRaw Milk on Insulin Doses and Carbohydrate Metabolism in Type1 Diabetic Patients. J Biomol Res Ther. 2018;7:159.
  • Abdalla KO. Camel milk is an alternative and a complementary treatment to the current parenteral insulin therapy of insulindependent diabetes mellitus. Gezira journal of health sciences. 2016 Dec;12(2):65-87.
  • Abdalla KO. Camel milk is an alternative and a complementarytreatment to the current parenteral insulin therapy of type 1diabetes mellitus. The 6th Annual Conference-the Medical &Health Sciences Studies, University of Khartoum. 2015;229.
  • Abdalla KO. An overview of the therapeutic effects of camel milkin the treatment of type 1 diabetes mellitus. J Bio-molecularResearch Therapeutics.2014 Mar;3(3):118.
  • Toth PP, Potter D, Ming EE. Prevalence of lipid abnormalities inthe United States: the National Health and Nutrition ExaminationSurvey 2003-2006. J Clin Lipidol. 2012 Jul-Aug;6(4):325-30.
  • LIPITOR. https://www.rxlist.com/lipitor-drug.htm#P.
  • Mohamed Mohamed Khair. Treatment experiences, Alsahafa news paper. 2013 Feb.
  • Lipitor (atorvastatin). https://www.iodine.com/drug/atorvastatin
  • Sboui A, Djegham M, Khorchani T, Hammadi M, Barhoumi K,etal. Effect of camel milk on blood glucose, cholesterol and totalproteins variations in alloxan-induced diabetic dogs. Int'l J. ofdiabetes and metabolism. 2010;8:5-11.
  • Abdalla KO (2016, 2012). Scientific monograph: Treatment of incurable ailments with camel's milk and urine by scientific research (book in Arabic). ISBN: 5-15-64-99942-978. Published by Sudan Ministry of Higher Education & Scientific Research and International University of Africa in Sudan.
  • Chaillous L, Carel JC, Thivolet C. Lack of effect of one year oral insulin therapy in recent-onset type 1 diabetes: Results of a multicentric randomized controlled trial. Diabetologia; 1999;42:A62- A62.
  • Stryer Lubert. Biochemistry, 4th Edi., New York: WH Freeman and Company. 2005:773-774.
  • Sircar S. Medical Physiology. Stuttgart: Thieme Publishing Group. 2007;537-538.
  • Voet D, Voet JG, W Pratt C. Fundamentals of Biochemistry .2nd Edi., John Wiley and Sons, Inc. 547, 556.
  • Rhoades RA, Bell DR. Medical physiology: principles for clinical medicine. 3rd edi., Philadelphia: Lippincott Williams & Wilkins. 2009;644-647.
  • Najjar S."Insulin Action: Molecular Basis of Diabetes".Encyclopedia of Life Sciences. John Wiley & Sons.2003 Jan.
  • Lecerf JM, de Lorgeril M."Dietary cholesterol: from physiology tocardiovascular risk". British J of Nutrition. 2011;106(1):6-14.
  • Ulmer H, Kelleher C, Diem G, Concin H. "Why Eve is not Adam:prospective follow-up in 149650 women and men of cholesteroland other risk factors related to cardiovascular and all-causemortality". J Women's Health (Larchmt). 2004 Jan;13(1):41-53.
  • Lewis GF, Rader DJ."New insights into the regulation of HDLmetabolism and reverse cholesterol transport" Circ. Res.2005;96(12):1221-1232.
  • Olson RE. "Discovery of the lipoproteins, their role in fattransport and their significance as risk factors". J Nutrition. 1998Feb;128(2):439S-443S.
  • Brown MS, Goldstein JS. How LDL receptors influence cholesterolandatherosclerosis.SciAm. 1984 Nov;251(5):57-66.
  • Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR.High density lipoprotein as a protective factor against coronaryheart disease. Am J Med. 1977 May;62(5):707-714.
  • Rhodes CM, Stryer L, Tasker R. Biochemistry 4th Edi., San Francisco: W.H. Freeman. 280, 703.
  • Tymoczko JL, Berg T, Stryer L, Berg JM. Biochemistry. SanFrancisco: W.H. Freeman. 2002; 726-727.
  • Agrawal RP, Beniwal R, Sharma S, Kochar DK, Tuteja FC, et al. Effectof raw camel milk in type 1 diabetic patients: 1 year randomizedstudy. Journal of Camel Practice and Research. 2005;12(1):27-35.
  • El-Agamy EI, Ruppanner R, Ismail A, Champagne CP, Assaf R.Antibacterial and antiviral activity of camel milk protectiveproteins. J Diary Res. 1992 May;59(2):169-75.